Cibc Asset Management Inc Praxis Precision Medicines, Inc. Transaction History

Cibc Asset Management Inc

  • $26.7 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023
BUY
$0.87 - $1.71 $257,019 - $505,176
295,425 Added 19.3%
1,825,910 $3.12 Million
Q2 2023

Aug 14, 2023
BUY
$0.83 - $1.18 $204,191 - $290,296
246,014 Added 19.15%
1,530,485 $1.76 Million
Q1 2023

May 12, 2023
BUY
$0.8 - $4.98 $723,867 - $4.51 Million
904,834 Added 238.34%
1,284,471 $1.04 Million
Q4 2022

Feb 13, 2023
BUY
$1.88 - $2.49 $713,717 - $945,296
379,637 New
379,637 $903,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0
View Full List

About Praxis Precision Medicines, Inc.

PRAX Quotes by TradingView
  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $1.79B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email